BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Treatment
59 results:

  • 1. treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
    Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
    Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    Giraud JS; Bièche I; Pasmant É; Tlemsani C
    Expert Opin Investig Drugs; 2023; 32(10):941-957. PubMed ID: 37747491
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms.
    Calabresi L; Carretta C; Romagnoli S; Rotunno G; Parenti S; Bertesi M; Bartalucci N; Rontauroli S; Chiereghin C; Castellano S; Gentili G; Maccari C; Vanderwert F; Mannelli F; Della Porta M; Manfredini R; Vannucchi AM; Guglielmelli P
    Am J Hematol; 2023 Oct; 98(10):1520-1531. PubMed ID: 37399248
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
    Yun J; Song H; Kim SM; Kim S; Kwon SR; Lee YE; Jeong D; Park JH; Kwon S; Yun H; Lee DS
    Hum Genomics; 2023 Feb; 17(1):13. PubMed ID: 36814285
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeted therapy in juvenile myelomonocytic leukemia: Where are we now?
    De Vos N; Hofmans M; Lammens T; De Wilde B; Van Roy N; De Moerloose B
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29930. PubMed ID: 36094370
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
    de Blank PMK; Gross AM; Akshintala S; Blakeley JO; Bollag G; Cannon A; Dombi E; Fangusaro J; Gelb BD; Hargrave D; Kim A; Klesse LJ; Loh M; Martin S; Moertel C; Packer R; Payne JM; Rauen KA; Rios JJ; Robison N; Schorry EK; Shannon K; Stevenson DA; Stieglitz E; Ullrich NJ; Walsh KS; Weiss BD; Wolters PL; Yohay K; Yohe ME; Widemann BC; Fisher MJ
    Neuro Oncol; 2022 Nov; 24(11):1845-1856. PubMed ID: 35788692
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
    Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
    Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities.
    Venkataramany AS; Schieffer KM; Lee K; Cottrell CE; Wang PY; Mardis ER; Cripe TP; Chandler DS
    Ann Oncol; 2022 Jun; 33(6):578-592. PubMed ID: 35339647
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Not Available].
    Oliveira AF; Tansini A; Toledo T; Balceiro R; Lee MLM; Villela N; Ikeuty P; Metze K; Lopes LF; Lorand-Metze I
    Br J Haematol; 2022 May; 197(3):339-348. PubMed ID: 35187646
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Subclinical Hypothyroidism as the Most Common Thyroid Dysfunction Status in Children With Down's Syndrome.
    Szeliga K; Antosz A; Skrzynska K; Kalina-Faska B; Januszek-Trzciakowska A; Gawlik A
    Front Endocrinol (Lausanne); 2021; 12():782865. PubMed ID: 35058880
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hemophagocytic Lymphohistiocytosis Secondary to Juvenile Myelomonocytic leukemia: A Case Report and Review of the Literature.
    Zheng F; Jia Y; Zhang L; Qin J
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e580-e584. PubMed ID: 34862352
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by nf1/PTEN loss.
    He S; Zimmerman MW; Layden HM; Berezovskaya A; Etchin J; Martel MW; Thurston G; Jing CB; van Rooijen E; Kaufman CK; Rodig SJ; Zon LI; Patton EE; Mansour MR; Look AT
    Oncogene; 2021 Sep; 40(38):5718-5729. PubMed ID: 34331013
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on
    Hrabovsky S; Vrzalova Z; Stika J; Jelinkova H; Jarosova M; Navrkalova V; Martenek J; Folber F; Salek C; Horacek JM; Pospisilova S; Mayer J; Doubek M
    Acta Oncol; 2021 Jun; 60(6):760-770. PubMed ID: 33750258
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemia.
    Damnernsawad A; Bottomly D; Kurtz SE; Eide CA; McWeeney SK; Tyner JW; Nechiporuk T
    Haematologica; 2022 Jan; 107(1):77-85. PubMed ID: 33375770
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Steroid receptor-associated and regulated protein is a biomarker in predicting the clinical outcome and treatment response in malignancies.
    Naderi A
    Cancer Rep (Hoboken); 2020 Oct; 3(5):e1267. PubMed ID: 32706923
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Iris juvenile xanthogranuloma in an infant - spontaneous hyphema and secondary glaucoma.
    Pantalon A; Ștefănache T; Danciu M; Zurac S; Chiseliță D
    Rom J Ophthalmol; 2017; 61(3):229-236. PubMed ID: 29450403
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Integrated molecular profiling of juvenile myelomonocytic leukemia.
    Murakami N; Okuno Y; Yoshida K; Shiraishi Y; Nagae G; Suzuki K; Narita A; Sakaguchi H; Kawashima N; Wang X; Xu Y; Chiba K; Tanaka H; Hama A; Sanada M; Ito M; Hirayama M; Watanabe A; Ueno T; Kojima S; Aburatani H; Mano H; Miyano S; Ogawa S; Takahashi Y; Muramatsu H
    Blood; 2018 Apr; 131(14):1576-1586. PubMed ID: 29437595
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic leukemia.
    Locatelli F; Algeri M; Merli P; Strocchio L
    Expert Rev Hematol; 2018 Feb; 11(2):129-143. PubMed ID: 29279013
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Type 1 neurofibromatosis: Onset of two tumors before the age of 5years].
    Remillieux M; Durand C; Sartelet H; Piolat C; Bourgeois E; Pommier P; Hameury F; Dieterich K; Vidaud D; Perret C
    Arch Pediatr; 2017 Oct; 24(10):986-990. PubMed ID: 28870819
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pediatric meningiomas: 65-year experience at a single institution.
    Grossbach AJ; Mahaney KB; Menezes AH
    J Neurosurg Pediatr; 2017 Jul; 20(1):42-50. PubMed ID: 28474981
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.